Chengde Wu

Title: Innovations and Contributions of Chengde Wu in Pharmaceutical Patents

Introduction

Chengde Wu, a prominent inventor based in Shanghai, China, has made significant contributions to the field of pharmaceuticals, holding an impressive 24 patents to his name. His innovative work, particularly in the development of therapeutic agents, underscores his dedication to advancing medical science.

Latest Patents

Wu's recent patents reflect his expertise and commitment to combating serious health issues. One of his notable inventions is the development of macrocyclic derivatives acting as XIa factor inhibitors. This patent discloses a class of macrocyclic derivatives along with a preparation method, pharmaceutical compositions containing these derivatives, and their utilization as therapeutic agents. These compounds are particularly aimed at treating and preventing thromboembolisms and other related diseases, highlighting their potential in critical therapeutic applications.

Another significant patent involves a diarylthiohydantoin compound, recognized as an androgen receptor antagonist. This application pertains to a compound that exhibits a strong antagonistic effect on the androgen receptor and demonstrates excellent antitumor capabilities. The invention emphasizes methods of preparation, pharmaceutical compositions, and therapeutic uses for treating cell proliferative diseases mediated by androgens.

Career Highlights

Chengde Wu has worked with renowned organizations throughout his career, including GlaxoSmithKline Intellectual Property Development Limited and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His experience with these companies has significantly influenced his research and innovation in pharmaceutical sciences.

Collaborations

Throughout his career, Wu has collaborated with notable colleagues such as Shuhui Chen and Tao Yu. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patented inventions.

Conclusion

In summary, Chengde Wu represents a prominent figure in the pharmaceutical patent landscape, with his 24 patents underscoring his innovative contributions to medicine. His work on macrocyclic derivatives and diarylthiohydantoin compounds not only showcases his ability to address pressing medical issues but also reflects the collaborative spirit that defines the field of pharmaceutical development.